Business Lines
Advanced Point-of-Care Diagnostics
Our focus is on the development of Point-of-Care IVD products for the early detection of diseases where timing is critical to improving outcomes. As a registered European IVD manufacturer. We leverage proprietary liquid biopsy technology to analyse biomarkers present in extracellular vesicles from just a single drop of blood. Our approach enables fast, economical and minimally invasive screening for serious conditions such as cancer and neurodegenerative diseases.
AI-Driven Models for Early Disease Screening
We develop advanced AI-driven models that integrate a wide range of healthcare indicators—including patient reported outcomes and experience measures, clinical data and results from our proprietary IVD tests. Our predictive algorithms generate personalized risk scores for the early detection of complex conditions such as cancers and neurodegenerative diseases, including Parkinson’s Disease.
This integrated approach enables earlier intervention, optimized screening, and supports precision-driven clinical research.
eCRF for Patient-Centered, Protocol-Compliant Research
Our eCRF platform, built on over a decade of clinical trial experience, streamlines secure, high-quality data collection for studies of any size and number of sites.
It ensures protocol compliance and uniquely allows both healthcare professionals and patients (including their families or caregivers) to contribute valuable, real-world insights.
This patient-centered approach improves data quality, speeds up trials, and supports regulatory requirements, making the platform a scalable asset for modern clinical research.
Let’s Accelerate Innovation in Diagnostics and Clinical Research with us
Contact Us